Literature DB >> 3348003

Antibody-mediated binding of a murine ecotropic Moloney retroviral vector to human cells allows internalization but not the establishment of the proviral state.

B Goud1, P Legrain, G Buttin.   

Abstract

We have attempted to introduce a neomycin-resistance gene, recombined in a murine (ecotropic) Moloney retrovirus, into HEp2 human cells which are resistant to infection by this retrovirus. To allow the binding of the retroviral vector on HEp2 cells, we have tested several antibody constructions between two monoclonal antibodies, one (mAb 5E9) directed against the human transferrin receptor and the other (mAb 615) directed against the gp70 envelope viral protein. The crosslinking of mAbs 5E9 and 615 by a sheep anti-murine kappa light chain antibody allowed the binding of virus on HEp2 cells. After incubation at 37 degrees, virus was internalized by HEp2 cells. However, no neomycin-resistant colonies of HEp2 cells have been obtained under various conditions. Our results suggest that binding and internalization of a retrovirus are not sufficient for establishment of the proviral state in cells which do not express a specific receptor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348003     DOI: 10.1016/0042-6822(88)90261-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Identification of the block in targeted retroviral-mediated gene transfer.

Authors:  Y Zhao; L Zhu; S Lee; L Li; E Chang; N W Soong; D Douer; W F Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses.

Authors:  P Roux; P Jeanteur; M Piechaczyk
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 3.  Development of retroviral vectors as safe, targeted gene delivery systems.

Authors:  W H Günzburg; B Salmons
Journal:  J Mol Med (Berl)       Date:  1996-04       Impact factor: 4.599

4.  Retroviral vectors displaying functional antibody fragments.

Authors:  S J Russell; R E Hawkins; G Winter
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

5.  Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens.

Authors:  J S Smith; J R Keller; N C Lohrey; C S McCauslin; M Ortiz; K Cowan; S E Spence
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

6.  Efficient inhibition of hepatitis B virus replication by hepatitis delta virus ribozymes delivered by targeting retrovirus.

Authors:  Chuan-Xi Wang; Yan-Qin Lu; Peng Qi; Long-Hua Chen; Jin-Xiang Han
Journal:  Virol J       Date:  2010-03-17       Impact factor: 4.099

7.  Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses.

Authors:  L M Albritton; J W Kim; L Tseng; J M Cunningham
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Infection by retroviral vectors outside of their host range in the presence of replication-defective adenovirus.

Authors:  R M Adams; M Wang; D Steffen; F D Ledley
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

Review 9.  Cancer gene therapy: principles, problems, and perspectives.

Authors:  F Herrmann
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.